| Q41320036 | Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats |
| Q34113027 | Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion |
| Q35025398 | Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning |
| Q37291743 | Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning |
| Q46151813 | CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion |
| Q39784439 | Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. |
| Q92097842 | Cannabinoids and Cardiovascular System |
| Q93343782 | Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle |
| Q38135915 | Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection |
| Q38593133 | Endocannabinoids and the Cardiovascular System in Health and Disease |
| Q37412217 | Endocannabinoids and the heart. |
| Q36360209 | From Protecting the Heart to Improving Athletic Performance - the Benefits of Local and Remote Ischaemic Preconditioning. |
| Q34233971 | Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery |
| Q44339072 | Interaction of δ and κ opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning |
| Q55176410 | Lung protection in patients undergoing pulmonary lobectomy: a new perspective for remote ischemic conditioning in surgery? |
| Q37364477 | Metabolic Signature of Remote Ischemic Preconditioning Involving a Cocktail of Amino Acids and Biogenic Amines |
| Q26771748 | Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks |
| Q82540952 | Remote Ischemic Preconditioning: Is the Groove in the Heart? |
| Q58566940 | Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update |
| Q57168888 | Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection |
| Q37987921 | Remote ischemic conditioning: from bench to bedside. |
| Q26828968 | Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop |
| Q38304828 | Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance. |
| Q34631989 | Remote ischemic preconditioning of cardiomyocytes inhibits the mitochondrial permeability transition pore independently of reduced calcium-loading or sarcKATP channel activation |
| Q42711574 | Remote preconditioning in normal and hypertrophic rat hearts |
| Q36346915 | Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies |
| Q50142905 | The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2. |
| Q37800142 | The Potential for Clinical Use of Cannabinoids in Treatment of Cardiovascular Diseases |
| Q33993080 | The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages |
| Q39667593 | The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies |
| Q37439386 | The emerging role of the endocannabinoid system in cardiovascular disease |
| Q37625397 | Translation of remote ischaemic preconditioning into clinical practice |
| Q85089270 | WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice |